Summary

The global anticoagulants market size reached USD 48.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 97.7 Billion by 2034, exhibiting a growth rate (CAGR) of 7.80% during 2026-2034. The rising cases of thrombotic disorders, sedentary lifestyles, and the improving healthcare sector represent some of the key factors driving the market.

Anticoagulants are medicines that prevent the formation of blood clots and reduce the chances of developing severe conditions, such as strokes and heart attacks. They assist in treating existing blood clots that resist the flow of blood through vessels and prevent them from getting larger and reducing the risk of serious complications. They are available in different strengths and colors and as oral, such as tablets and capsules, and injectable variants. At present, direct oral anticoagulants (DOAc) are increasingly being prescribed on account of their ease of use and lack of need for routine monitoring.


Anticoagulants Market Trends:
The growing geriatric population and increasing prevalence of human immunodeficiency virus (HIV), lyme disease, obesity, hepatitis C, chronic inflammation, and cardiovascular disorders across the globe represent one of the key factors positively influencing the market across the globe. In addition, rising cases of thrombotic disorders, such as pulmonary embolism (PE), on account of sedentary lifestyles and hectic work schedules are inducing the growth of heart-related diseases worldwide. Moreover, extended sitting, smoking, trauma, blood disorders, and autoimmune diseases are increasing the risk of blood clotting in different parts of the body, which, in turn, is catalyzing the demand for anticoagulants. Apart from this, increasing advancements in research and development (R&D) activities in drug discovery and the integration of advanced technologies, such as artificial intelligence (AI) and machine learning (ML) to analyze large amounts of data, identify potential drug candidates and develop a new drug is fueling the market growth. In line with this, healthcare providers are focusing on personalizing anticoagulant therapy for individual patients based on their genetic and clinical data. AI assists in identifying the most effective dose and type of anticoagulant for the patient, which, in turn, reduces the risk of complications and improves outcomes. Furthermore, favorable initiatives by non-profitable organizations to promote awareness about cardiovascular health and the growing partnerships between governments of various countries and public health agencies to prevent heart disease and strokes are propelling the growth of the market worldwide. Other factors like the burgeoning healthcare sector and increasing affordability and accessibility of drugs are stimulating the growth of the market.


Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global anticoagulants market report, along with forecasts at the global, regional and country level from 2026-2034. Our report has categorized the market based on drug class, route of administration, distribution channel and application.


Drug Class Insights:
• Novel Oral Anticoagulants (NOACs)
• Heparin and Low Molecular Weight Heparin (LMWH)
• Vitamin K Antagonist
• Others
The report has provided a detailed breakup and analysis of the anticoagulants market based on the drug class. This includes novel oral anticoagulants (NOACs), heparin and low molecular weight heparin (LMWH), vitamin K antagonist, and others. According to the report, novel oral anticoagulants (NOACs) represented the largest segment.


Route of Administration Insights:
• Oral Anticoagulant
• Injectable Anticoagulant
A detailed breakup and analysis of the anticoagulants market based on the route of administration has also been provided in the report. This includes oral anticoagulant and injectable anticoagulant. According to the report, oral anticoagulant accounted for the largest market share.


Distribution Channel Insights:
• Hospital Pharmacies
• Retail Pharmacies
• Online Stores
• Others
A detailed breakup and analysis of the anticoagulants market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, online stores, and others. According to the report, hospital pharmacies accounted for the largest market share.


Application Insights:
• Atrial Fibrillation and Heart Attack
• Stroke
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Others
A detailed breakup and analysis of the anticoagulants market based on the application has also been provided in the report. This includes atrial fibrillation and heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others. According to the report, atrial fibrillation and heart attack accounted for the largest market share.


Regional Insights:
• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for anticoagulants. Some of the factors driving the North America anticoagulants market included the increasing prevalence of thrombotic disorders, developed healthcare sector, ongoing research and development (R&D) activities in drug discovery etc.


Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global anticoagulants market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Alexion Pharmaceuticals Inc, Aspen Holdings, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company Limited, Dr. Reddy’s Laboratories Ltd, GlaxoSmithKline plc, Johnson & Johnson Private Limited, Pfizer Inc., Sanofi, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report


Key Questions Answered in This Report
1.What was the size of the global anticoagulants market in 2025?
2.What is the expected growth rate of the global anticoagulants market during 2026-2034?
3.What are the key factors driving the global anticoagulants market?
4.What has been the impact of COVID-19 on the global anticoagulants market?
5.What is the breakup of the global anticoagulants market based on the drug class?
6.What is the breakup of the global anticoagulants market based on the route of administration?
7.What is the breakup of the global anticoagulants market based on the distribution channel?
8.What is the breakup of the global anticoagulants market based on the application?
9.What are the key regions in the global anticoagulants market?
10.Who are the key players/companies in the global anticoagulants market?

ページTOPに戻る

Table of Contents

1   Preface
2   Scope and Methodology
2.1    Objectives of the Study
2.2    Stakeholders
2.3    Data Sources
2.3.1    Primary Sources
2.3.2    Secondary Sources
2.4    Market Estimation
2.4.1    Bottom-Up Approach
2.4.2    Top-Down Approach
2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
4.1    Overview
4.2    Key Industry Trends
5   Global Anticoagulants Market
5.1    Market Overview
5.2    Market Performance
5.3    Impact of COVID-19
5.4    Market Forecast
6   Market Breakup by Drug Class
6.1    Novel Oral Anticoagulants (NOACs)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2    Heparin and Low Molecular Weight Heparin (LMWH)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3    Vitamin K Antagonist
6.3.1 Market Trends
6.3.2 Market Forecast
6.4    Others
6.4.1 Market Trends
6.4.2 Market Forecast
7   Market Breakup by Route of Administration
7.1    Oral Anticoagulant
7.1.1 Market Trends
7.1.2 Market Forecast
7.2    Injectable Anticoagulant
7.2.1 Market Trends
7.2.2 Market Forecast
8   Market Breakup by Distribution Channel
8.1    Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2    Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3    Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
8.4    Others
8.4.1 Market Trends
8.4.2 Market Forecast
9   Market Breakup by Application
9.1    Atrial Fibrillation and Heart Attack
9.1.1 Market Trends
9.1.2 Market Forecast
9.2    Stroke
9.2.1 Market Trends
9.2.2 Market Forecast
9.3    Deep Vein Thrombosis (DVT)
9.3.1 Market Trends
9.3.2 Market Forecast
9.4    Pulmonary Embolism (PE)
9.4.1 Market Trends
9.4.2 Market Forecast
9.5    Others
9.5.1 Market Trends
9.5.2 Market Forecast
10   Market Breakup by Region
10.1    North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2    Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3    Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4    Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5    Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11  SWOT Analysis
11.1    Overview
11.2    Strengths
11.3    Weaknesses
11.4    Opportunities
11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
13.1    Overview
13.2    Bargaining Power of Buyers
13.3    Bargaining Power of Suppliers
13.4    Degree of Competition
13.5    Threat of New Entrants
13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape
15.1    Market Structure
15.2    Key Players
15.3    Profiles of Key Players
15.3.1    Alexion Pharmaceuticals Inc
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2    Aspen Holdings
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3    Bayer AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4    Boehringer Ingelheim International GmbH
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5    Bristol-Myers Squibb Company
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6    Daiichi Sankyo Company Limited
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 Financials
15.3.6.4 SWOT Analysis
15.3.7    Dr. Reddy’s Laboratories Ltd
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8    GlaxoSmithKline plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9    Johnson & Johnson Private Limited
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10    Pfizer Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11    Sanofi
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis

ページTOPに戻る

List of Tables/Graphs

List of Figures
Figure 1: Global: Anticoagulants Market: Major Drivers and Challenges
Figure 2: Global: Anticoagulants Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Anticoagulants Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Anticoagulants Market: Breakup by Drug Class (in %), 2025
Figure 5: Global: Anticoagulants Market: Breakup by Route of Administration (in %), 2025
Figure 6: Global: Anticoagulants Market: Breakup by Distribution Channel (in %), 2025
Figure 7: Global: Anticoagulants Market: Breakup by Application (in %), 2025
Figure 8: Global: Anticoagulants Market: Breakup by Region (in %), 2025
Figure 9: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 10: Global: Anticoagulants (Novel Oral Anticoagulants-NOACs) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 11: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 12: Global: Anticoagulants (Heparin and Low Molecular Weight Heparin-LMWH) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 13: Global: Anticoagulants (Vitamin K Antagonist) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 14: Global: Anticoagulants (Vitamin K Antagonist) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 15: Global: Anticoagulants (Other Drug Classes) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 16: Global: Anticoagulants (Other Drug Classes) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 17: Global: Anticoagulants (Oral Anticoagulant) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 18: Global: Anticoagulants (Oral Anticoagulant) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 19: Global: Anticoagulants (Injectable Anticoagulant) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 20: Global: Anticoagulants (Injectable Anticoagulant) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 21: Global: Anticoagulants (Hospital Pharmacies) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 22: Global: Anticoagulants (Hospital Pharmacies) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 23: Global: Anticoagulants (Retail Pharmacies) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 24: Global: Anticoagulants (Retail Pharmacies) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 25: Global: Anticoagulants (Online Stores) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 26: Global: Anticoagulants (Online Stores) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 27: Global: Anticoagulants (Other Distribution Channels) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 28: Global: Anticoagulants (Other Distribution Channels) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 29: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 30: Global: Anticoagulants (Atrial Fibrillation and Heart Attack) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 31: Global: Anticoagulants (Stroke) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 32: Global: Anticoagulants (Stroke) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 33: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 34: Global: Anticoagulants (Deep Vein Thrombosis-DVT) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 35: Global: Anticoagulants (Pulmonary Embolism-PE) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 36: Global: Anticoagulants (Pulmonary Embolism-PE) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 37: Global: Anticoagulants (Other Applications) Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 38: Global: Anticoagulants (Other Applications) Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 39: North America: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 40: North America: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 41: United States: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 42: United States: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 43: Canada: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 44: Canada: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 45: Asia-Pacific: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 46: Asia-Pacific: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 47: China: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 48: China: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 49: Japan: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 50: Japan: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 51: India: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 52: India: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 53: South Korea: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 54: South Korea: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 55: Australia: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 56: Australia: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 57: Indonesia: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 58: Indonesia: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 59: Others: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 60: Others: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 61: Europe: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 62: Europe: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 63: Germany: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 64: Germany: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 65: France: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 66: France: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 67: United Kingdom: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 68: United Kingdom: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 69: Italy: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 70: Italy: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 71: Spain: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 72: Spain: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 73: Russia: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 74: Russia: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 75: Others: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 76: Others: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 77: Latin America: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 78: Latin America: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 79: Brazil: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 80: Brazil: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 81: Mexico: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 82: Mexico: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 83: Others: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 84: Others: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 85: Middle East and Africa: Anticoagulants Market: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2020 & 2025
Figure 86: Middle East and Africa: Anticoagulants Market: Breakup by Country (in %), 2025
Figure 87: Middle East and Africa: Anticoagulants Market Forecast: Sales Value (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Figure 88: Global: Anticoagulants Industry: SWOT Analysis
Figure 89: Global: Anticoagulants Industry: Value Chain Analysis
Figure 90: Global: Anticoagulants Industry: Porter's Five Forces Analysis

List of Tables
Table 1: Global: Anticoagulants Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Anticoagulants Market Forecast: Breakup by Drug Class (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Table 3: Global: Anticoagulants Market Forecast: Breakup by Route of Administration (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Table 4: Global: Anticoagulants Market Forecast: Breakup by Distribution Channel (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Table 5: Global: Anticoagulants Market Forecast: Breakup by Application (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Table 6: Global: Anticoagulants Market Forecast: Breakup by Region (in Million ​​​​​​​​​​​​​​​​​​​​​USD), 2026-2034
Table 7: Global: Anticoagulants Market: Competitive Structure
Table 8: Global: Anticoagulants Market: Key Players